Proprio Receives FDA Clearance for World’s First AI Surgical Guidance Platform with Real-Time Measurements

Proprio has secured FDA 510(k) clearance for real-time intraoperative measurements in its Paradigm AI surgical guidance platform, the first technology enabling 3D dynamic visualization and continuous measurement during procedures. Already adopted by Duke Health and UW Medicine, the system eliminates radiation exposure by replacing traditional X-ray/CT verification methods, allowing surgeons to monitor spinal alignment and implant placement in real time. “This lets us measure critical outcomes during surgery while protecting the operating teams,” said Duke neurosurgeon Dr. Christopher Shaffrey, a Proprio advisor.

The platform addresses a historical challenge in surgery: previously, measurements required scrubbing out for scans, delaying procedures and forcing reliance on preoperative plans. UW Medicine’s Dr. Rick Bransford notes that the system provides “trajectory guidance for screw placement with zero radiation” while enabling real-time alignment adjustments. Proprio CEO Gabriel Jones emphasizes that this shift from “educated guesswork to data-driven certainty” could reduce revision surgeries and set new standards for surgical training through its recorded case database.

With hundreds of leading surgeons contributing to its AI models, Proprio is building what it describes as the most comprehensive surgical dataset – combining real-time metrics, surgeon expertise, and outcome data. This clearance follows Proprio’s initial FDA authorization, marking the accelerated adoption of AI-guided precision in operating rooms.